Skip to content
Dose Brief
Menu
No. 137 here · Grade C

MYRNK review

A longevity storefront that happens to sell GLP-1s: semaglutide and tirzepatide sit on the same shelf as NAD+, sermorelin, enclomiphene and a $399 DNA panel, every one of them priced "from".

Visit MYRNK Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $197/mo (compounded)
Tirzepatide
From $297/mo (compounded)
Coverage
Not published
Brand-name
Compounded only

Prices read from MYRNK's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 13 September 2026, read live off the provider's own pages that day rather than taken on trust. There is no earlier reading here to compare against, so the direction is "new" rather than stable — a first observation is not a trend. Every line on this storefront is a "From" price, so there is no ceiling to track a movement against yet; the next reading will have to establish whether the floor is also the rate.

The scorecard

MYRNK scored on our six Brief Score factors. See the methodology.

Price Stability60/100
Supply Reliability72/100
Transparency58/100
Access Breadth88/100
Clinical Oversight72/100
Track Record68/100

What we like

  • Prices seven treatment lines on one page before any intake, GLP-1s included
  • Both molecules are on the shelf, with the semaglutide line the cheaper of the two at a published floor
  • States compounding in the USA and 1-on-1 calls with U.S. doctors, with free shipping and no hidden fees claimed
  • Delivery in 48 hours is advertised on the same page as the prices

The caveats

  • Every figure is a "From" floor — no dose ladder, no plan terms and no ceiling is published for any line
  • No states-served list appears anywhere on the page
  • No compounding pharmacy is named and no 503A or 503B class is stated
  • The GLP-1 lines sit among six other treatments, so the weight-loss program is the least detailed thing on a busy shelf

The brief

Best for: A reader who wants GLP-1 care and peptide or hormone lines from one account, and who will get a firm figure before starting. A longevity storefront that happens to sell GLP-1s: semaglutide and tirzepatide sit on the same shelf as NAD+, sermorelin, enclomiphene and a $399 DNA panel, every one of them priced "from".

Ranked #137 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about MYRNK.

Closest here

The providers scoring nearest MYRNK — the realistic shortlist if you're weighing it.

Weighing MYRNK against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs MYRNK, and every provider that outranks it is listed on the MYRNK alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect MYRNK's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on MYRNK's site. Not medical advice; see our disclosure.

← Back to all rankings